---
$id: https://graph.org.ai/products/commodity/51141567
$type: Product
source: UNSPSC
code: "51141567"
title: "Milacemide"
class: "51141500"
classTitle: "Anticonvulsants"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Milacemide

**UNSPSC Code**: 51141567
**Class**: [Anticonvulsants](Anticonvulsants.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anticonvulsant agent with the molecular formula C7H16N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0HXT24RECU, chemically known as acetamide, 2-(pentylamino)- but generally known as milacemide, which bears US NIH Compound Identifier 53569. European Medicines Agency schedules Milacemide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08960MIG. The term MILACEMIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 37, No. 6, 1983, List 23). MILACEMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule milacemide under HS 29241900 and SITC 51471. As of Q4 2014, MILACEMIDE remains the US FDA Preferred Term for this commodity. Milacemide bears US NLM identifiers UMLS ID C0066545 and NCI Concept Code C81467. SMILES: O=C(N)CNCCCCC.

